Furthermore, elevated expression and signaling of CXCR2 is correlated with aggressive cancer phenotypes and a poor prognosis in various cancers, such as lung cancer, colorectal cancer, pancreatic cancer, prostate cancer, breast cancer, gastric cancer and squamous cell carcinoma [9]. The gene discussed is CXCR2; the disease is breast cancer.